Neurothera Labs Inc.

Tourette’s syndrome and tic disorder management

Neurothera Labs Inc. focuses on clinical research in Tourette’s syndrome affecting adults receiving out-patient care, with interest in the control of motor and vocal tics and related symptom burden.

  • Tic severity reduction
  • Adult neuropsychiatric disorders
  • Out-patient neurological care

The sponsor’s research activity is centered on therapeutic options for adult patients living with persistent tic symptoms in community-based care settings.

Neuropsychiatry and central nervous system therapeutics

The clinical portfolio reflects an interest in neuropsychiatric conditions involving central nervous system regulation, particularly disorders where behavioral and motor symptoms overlap.

  • Behavioral symptom control
  • Motor function regulation
  • Neurological symptom management

This area highlights a therapeutic focus on conditions requiring targeted treatment of neurological and psychiatric manifestations in adults.

Safety and tolerability of oral therapies

Neurothera Labs Inc. also studies oral treatment approaches with attention to safety and tolerability in adult populations, supporting treatment development for chronic neurological symptoms.

  • Oral neurotherapeutics
  • Long-term treatment tolerability
  • Adult treatment adherence

The sponsor’s research interest includes practical therapeutic use in routine clinical care, where convenience and tolerability are important considerations.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Dronabinol and Palmidrol for Adults with Tourette Syndrome

    Recruiting

    2 1
    Investigated drugs:
    Germany